Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
5,028.08
4,626.45
4,134.36
3,304.59
2,813.37
3,069.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,028.08
4,626.45
4,134.36
3,304.59
2,813.37
3,069.27
Raw Material Cost
63.11
42.17
32.29
16.95
14.27
9.29
Purchase of Finished goods
3,635.35
3,435.76
3,374.54
2,737.39
2,301.90
2,521.39
(Increase) / Decrease In Stocks
15.21
54.09
-169.10
-166.64
-93.81
-105.44
Employee Cost
646.41
531.84
464.92
396.53
280.17
338.65
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.00
0.00
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
229.81
211.85
183.49
136.32
90.76
88.71
Total Expenditure (Excl Depreciation)
4,589.89
4,275.71
3,886.14
3,120.56
2,593.29
2,852.60
Operating Profit (PBDIT) excl Other Income
438.19
350.74
248.22
184.03
220.08
216.67
Other Income
50.73
32.83
29.55
32.38
18.31
21.55
Operating Profit (PBDIT)
488.92
383.57
277.77
216.41
238.39
238.22
Interest
87.01
75.74
71.31
60.76
47.85
54.84
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
401.91
307.83
206.46
155.65
190.54
183.38
Depreciation
206.92
185.64
165.00
125.76
85.24
88.27
Profit Before Tax
194.99
122.17
41.46
29.90
105.31
95.10
Tax
39.36
23.26
9.45
6.36
22.02
31.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
155.64
98.91
32.02
23.54
83.29
63.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
155.64
98.91
32.02
23.54
83.29
63.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
0.04
0.02
-0.42
0.27
0.21
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
155.67
98.99
32.08
23.18
84.07
63.86
Equity Capital
23.96
23.94
23.91
23.86
23.86
0.45
Face Value
2.0
2.0
2.0
2.0
2.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
4.81
3.82
1.14
1.12
1.52
1.69
Operating Profit Margin (Excl OI)
8.71%
7.58%
6.0%
5.57%
7.82%
7.06%
Gross Profit Margin
7.99%
6.65%
4.99%
4.71%
6.77%
5.97%
PAT Margin
3.1%
2.14%
0.77%
0.71%
2.96%
2.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 8.68% vs 11.90% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 57.26% vs 208.57% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 24.93% vs 41.30% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 14.88% vs 6.21% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Medplus Health With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
5,028.08
6,221.65
-1,193.57
-19.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,028.08
6,221.65
-1,193.57
-19.18%
Raw Material Cost
63.11
811.83
-748.72
-92.23%
Purchase of Finished goods
3,635.35
1,953.37
1,681.98
86.11%
(Increase) / Decrease In Stocks
15.21
-246.31
261.52
106.18%
Employee Cost
646.41
701.07
-54.66
-7.80%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.00
0.00
-0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
229.81
2,010.03
-1,780.22
-88.57%
Total Expenditure (Excl Depreciation)
4,589.89
5,229.99
-640.10
-12.24%
Operating Profit (PBDIT) excl Other Income
438.19
991.66
-553.47
-55.81%
Other Income
50.73
62.70
-11.97
-19.09%
Operating Profit (PBDIT)
488.92
1,054.36
-565.44
-53.63%
Interest
87.01
278.16
-191.15
-68.72%
Exceptional Items
0.00
-41.31
41.31
100.00%
Gross Profit (PBDT)
401.91
734.89
-332.98
-45.31%
Depreciation
206.92
585.14
-378.22
-64.64%
Profit Before Tax
194.99
149.75
45.24
30.21%
Tax
39.36
33.24
6.12
18.41%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
155.64
116.51
39.13
33.59%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
155.64
116.51
39.13
33.59%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.01
0.00
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
155.67
116.51
39.16
33.61%
Equity Capital
23.96
1,220.29
-1,196.33
-98.04%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
7.99%
11.81%
0.00
-3.82%
PAT Margin
3.10%
1.87%
0.00
1.23%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 5,028.08 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 8.68% vs 11.90% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 155.67 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 57.26% vs 208.57% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 438.19 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 24.93% vs 41.30% in Dec 2024
Nine Monthly - Interest
Interest 87.01 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 14.88% vs 6.21% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.71%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
